focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-First Marblehead, Bellicum, OvaScience

Thu, 18th Dec 2014 17:59

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stocks rose on Thursday, with each of the major indexesclimbing more than 1 percent, building on the prior session'srally after the U.S. Federal Reserve's policy statement and oilprices that showed signs of steadying. The Dow Jones industrialaverage rose 0.75 percent, the S&P 500 were up 0.8percent and the Nasdaq Composite were up 1.36 percent.

** FIRST MARBLEHEAD CORP, $5.01, +138.57 pct

The education loan provider said the Internal RevenueService (IRS) has informed the company that it would notchallenge federal tax refunds the company received. IRS proposedin September 2013 to disallow a loss that resulted in the taxrefunds of $176.6 million and $45.1 million.

** BELLICUM PHARMACEUTICALS INC, $27.16, +42.95 pct

The biopharmaceutical company's shares rose as much as 40percent on its debut on Thursday. The company offerd 7.35million shares at $19, above $15-$17 marketed range.

** OVASCIENCE INC, $47.35, +35.44 pct

Wedbush Securities raised its rating on the fertilitytreatment developer to "outperform" from "neutral" after companysaid it will launch 2 fertility products and gave update on theprogress of third treatment.

** SILICON IMAGE INC, $4.98, -26.11 pct

The chipmaker said it expects revenue to fall 10 percent in2015 due to fewer mobile design wins from one its largestcustomers.

** COMSTOCK RESOURCES INC, $5.93, -13.43 pct

The oil and gas producer said it plans to suspend oildrilling in Eagle Ford shale properties in south and east Texasand Tuscaloosa Marine shale in Mississippi as oil prices plunge.

** TETRAPHASE PHARMACEUTICALS INC, $38.2, +15.09pct

The drug developer said its antibiotic to treat complicatedintra-abdominal infections was as effective as Merck & Co Inc's ertapenem in a late-stage study.

** DUNKIN' BRANDS GROUP INC, $42.395, -8.28 pct

The Dunkin' Donuts restaurant operator cut its 2015 forecastfor same-store sales growth in the United States and operatingincome growth, citing slowing sales of packaged coffee in itsrestaurants.

** AGENUS INC, $3.836, +14.51 pct

** GLAXOSMITHKLINE PLC, $43.2, +2.76 pct

The biotechnology company said an experimental vaccineagainst shingles by its partner GlaxoSmithKline met itsgoal in a late-stage study. Agenus will get royalties onpotential commercial sales of the vacine.

** ORACLE INC, $44.53, +8.19 pct

The software maker reported a 3.5 percent increase inquarterly revenue on Wednesday, beating Wall Street'sexpectations, as sales at its closely watched cloud servicesbusiness rose 45 percent.

** KIRBY CORP, $82.1, -7.49 pct

The tank bank operator lowered fourth-quarter earningsestimate to $1.10-$1.20 per share from $1.30-$1.40 per share.The company also lowered its full-year earnings estimate to$4.84 to $4.94 per share from $5.04-$5.14 per share.

** CEPHEID, $53.74, +7.93 pct

Analysts at BofA Merrill Lynch upgraded the biotechnologycompany's stock to "buy" from "neutral". The analysts saidCepheid is poised to gain market share, citing a growing menu ofdiagnostic tests, improved execution with 7,500 placements ofthe company's GeneXpert systems and slow response from itscompetitors.

** WINNEBAGO INDUSTRIES INC, $21.85, -8.39 pct

The maker of motorhomes and camping trailers reported alower-than-expected profit as a shortage of workers at a keyplant in rural Iowa and trouble sourcing key components fromsuppliers stymied production of the company's recreationalvehicles.

** REAL GOODS SOLAR INC, $0.6689, +15.33 pct

The solar company said it won more than 80 contracts toinstall rooftop solar power systems on homes and smallbusinesses. The company said the projects represent more than600kW of solar power.

** ACCENTURE PLC, $89, +4.34 pct

The consulting and outsourcing company raised its revenueforecast for fiscal 2015 after contract wins helped the companypost better-than-expected first-quarter earnings and revenue. The company said it expects revenue growth of 5-8 percent forthe year ending August on a local currency basis, up from the4-7 percent growth it had estimated earlier.

** RITE AID CORP, $6.77, +11.72 pct

The U.S. drugstore chain raised its full-year earningsforecast after cutting it twice this year as higher sales ofprescription drugs pushed up its profit and revenue in the thirdquarter.

** CONAGRA FOODS INC, $36.04, -2.86 pct

The Slim Jim Beef Jerky and Chef Boyardee pasta makerreported quarterly sales that missed estimates due to weakdemand for branded foods and said recovery in itsunder-performing private-label business would take longer thanexpected.

** AK STEEL HOLDING CORP, $6.08, +9.35 pct

The steel maker said it expects fourth-quarter shipments tojump 37 percent compared with the third quarter, helped byacquisitions and strong demand from auto industry.

** THE PANTRY INC, $36.5567, +2.92 pct

Canada's Alimentation Couche-Tard Inc will buysmaller U.S. rival Pantry for about $861 million, a deal thatpositions it as one of the top convenience store operators inNorth America.

** BLACKBERRY LTD, $10.0639, +0.84 pct

The Canadian mobile technology company launched itslong-awaited Classic on Wednesday, a smartphone it hopes willhelp it win back market share and woo those still using olderversions of its physical keyboard devices.

** ZAGG INC, $6.13, +15.01 pct

The mobile accessories maker raised its full-year net salesforecast to $250 million-$255 million from previous range of$225 million-$235 million. The forecast also beat analysts'average estimate of $232.5 million, according to Thomson ReutersI/B/E/S.

** EXXON MOBIL CORP, $90.32, +1.46 pct

** CHEVRON CORP, $108.07, +1.93 pct

** CONOCOPHILLIPS, $68.81, +2.79 pct

** CHESAPEAKE ENERGY CORP, $18.98, +1.61 pct

Oil company stocks rise after Brent crude jumps 3.3percent to above $63/bbl, extending a rebound from 5-year lowsthis week as more energy firms cut investment in new production.

** HERTZ GLOBAL HOLDINGS INC, $22.75, +6.76 pct

Carl Icahn, the rental car company's largest shareholder,raised stake in the company to 11.34 percent from 10.77 percent.Icahn revealed an 8.48 percent stake in Hertz in August; he hassince ousted CEO Mark Frissora and won three board seats at thecompany.

** ALCATEL-LUCENT SA, $3.52, +6.02 pct

** NOKIA, $8.01, +1.91 pct

Two of Europe's top three remaining telecommunicationsequipment companies, Nokia and Alcatel-Lucent, have revivedtalks on a possible merger, Germany's Manager Magazin reportedon Thursday, citing company sources.

** HERMAN MILLER INC, $29.52, -5.08 pct

The furniture maker forecast full-year profit and saleslargely below analysts' estimates. The company also reportedsecond-quarter adjusted profit of 51 cents per share, belowaverage analyst estimate of 52 cents.

** OCWEN FINANCIAL CORP, $20.69, -2.36 pct

The mortgage servicer is facing scrutiny from New York stateand the federal government over whether the company improperlystalled short sales of property to collect more fees, Bloombergreported, citing sources.

** GENWORTH FINANCIAL INC, $7.83, -1.26 pct

The life and mortgage insurer said the review of long termcare insurance active life margins is taking longer thanexpected. The company said it now expects to complete review onor before fourth quarter results in February.

** JABIL CIRCUIT INC, $20.73, +3.29 pct

The company, which makes phone casings for Apple Inc, forecasts second-quarter revenue above estimates,boosted by strong sales of iPhone 6 and 6 Plus. The companyforecast second quarter core earnings of 39-50 cents per share,higher than analysts' average estimate of profit of 38 cents pershare.

** NATIONAL BANK OF GREECE, $1.945, -2.26 pct

The largest Greek bank's U.S.-listed shares down afterfirst-round presidential vote in Greece saw Prime MinisterAntonis Samaras lose by larger-than-expected margin. (Compiled by Anannya Pramanick in Bengaluru; Edited by DonSebastian)

More News
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.